200 related articles for article (PubMed ID: 26231918)
1. 2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia.
Soldevilla MM; Villanueva H; Bendandi M; Inoges S; López-Díaz de Cerio A; Pastor F
Biomaterials; 2015 Oct; 67():274-85. PubMed ID: 26231918
[TBL] [Abstract][Full Text] [Related]
2. Selection of aptamers for molecular recognition and characterization of cancer cells.
Tang Z; Shangguan D; Wang K; Shi H; Sefah K; Mallikratchy P; Chen HW; Li Y; Tan W
Anal Chem; 2007 Jul; 79(13):4900-7. PubMed ID: 17530817
[TBL] [Abstract][Full Text] [Related]
3. Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy.
Mahlknecht G; Sela M; Yarden Y
Methods Mol Biol; 2015; 1317():3-15. PubMed ID: 26072398
[TBL] [Abstract][Full Text] [Related]
4. The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T-cell-dependent tumor immunity.
Mangsbo SM; Broos S; Fletcher E; Veitonmäki N; Furebring C; Dahlén E; Norlén P; Lindstedt M; Tötterman TH; Ellmark P
Clin Cancer Res; 2015 Mar; 21(5):1115-26. PubMed ID: 25316820
[TBL] [Abstract][Full Text] [Related]
5. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
Delač M; Motaln H; Ulrich H; Lah TT
Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
[TBL] [Abstract][Full Text] [Related]
6. Cell-SELEX-based selection and characterization of a G-quadruplex DNA aptamer against mouse dendritic cells.
Moghadam M; Sankian M; Abnous K; Varasteh A; Taghdisi SM; Mahmoudi M; Ramezani M; Gholizadeh Z; Ganji A
Int Immunopharmacol; 2016 Jul; 36():324-332. PubMed ID: 27232653
[TBL] [Abstract][Full Text] [Related]
7. Identification of liver cancer-specific aptamers using whole live cells.
Shangguan D; Meng L; Cao ZC; Xiao Z; Fang X; Li Y; Cardona D; Witek RP; Liu C; Tan W
Anal Chem; 2008 Feb; 80(3):721-8. PubMed ID: 18177018
[TBL] [Abstract][Full Text] [Related]
8. Use of oligonucleotide aptamer ligands to modulate the function of immune receptors.
Gilboa E; McNamara J; Pastor F
Clin Cancer Res; 2013 Mar; 19(5):1054-62. PubMed ID: 23460536
[TBL] [Abstract][Full Text] [Related]
9. Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy.
Hervas-Stubbs S; Soldevilla MM; Villanueva H; Mancheño U; Bendandi M; Pastor F
Oncotarget; 2016 Jan; 7(4):4522-30. PubMed ID: 26683225
[TBL] [Abstract][Full Text] [Related]
10. RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.
Mason NJ; Coughlin CM; Overley B; Cohen JN; Mitchell EL; Colligon TA; Clifford CA; Zurbriggen A; Sorenmo KU; Vonderheide RH
Gene Ther; 2008 Jul; 15(13):955-65. PubMed ID: 18337841
[TBL] [Abstract][Full Text] [Related]
11. In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX.
Shi H; Tang Z; Kim Y; Nie H; Huang YF; He X; Deng K; Wang K; Tan W
Chem Asian J; 2010 Oct; 5(10):2209-13. PubMed ID: 20806314
[TBL] [Abstract][Full Text] [Related]
12. Selection of DNA aptamers against epidermal growth factor receptor with high affinity and specificity.
Wang DL; Song YL; Zhu Z; Li XL; Zou Y; Yang HT; Wang JJ; Yao PS; Pan RJ; Yang CJ; Kang DZ
Biochem Biophys Res Commun; 2014 Oct; 453(4):681-5. PubMed ID: 25242523
[TBL] [Abstract][Full Text] [Related]
13. Cancer immunotherapy via nucleic acid aptamers.
Khedri M; Rafatpanah H; Abnous K; Ramezani P; Ramezani M
Int Immunopharmacol; 2015 Dec; 29(2):926-936. PubMed ID: 26603636
[TBL] [Abstract][Full Text] [Related]
14. Dimerization of an aptamer generated from Ligand-guided selection (LIGS) yields a high affinity scaffold against B-cells.
Batool S; Argyropoulos KV; Azad R; Okeoma P; Zumrut H; Bhandari S; Dekhang R; Mallikaratchy PR
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):232-240. PubMed ID: 30342154
[TBL] [Abstract][Full Text] [Related]
15. A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection.
Ji K; Lim WS; Li SF; Bhakoo K
Anal Bioanal Chem; 2013 Aug; 405(21):6853-61. PubMed ID: 23842900
[TBL] [Abstract][Full Text] [Related]
16. Expression of new antigens on tumor cells by inhibiting nonsense-mediated mRNA decay.
Gilboa E
Immunol Res; 2013 Dec; 57(1-3):44-51. PubMed ID: 24198064
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.
Zhao N; Pei SN; Qi J; Zeng Z; Iyer SP; Lin P; Tung CH; Zu Y
Biomaterials; 2015 Oct; 67():42-51. PubMed ID: 26204224
[TBL] [Abstract][Full Text] [Related]
18. One round of SELEX for the generation of DNA aptamers directed against KLK6.
Arnold S; Pampalakis G; Kantiotou K; Silva D; Cortez C; Missailidis S; Sotiropoulou G
Biol Chem; 2012 Apr; 393(5):343-53. PubMed ID: 22505517
[TBL] [Abstract][Full Text] [Related]
19. In vitro selection of RNA aptamers that selectively bind danofloxacin.
Han SR; Yu J; Lee SW
Biochem Biophys Res Commun; 2014 Jun; 448(4):397-402. PubMed ID: 24792181
[TBL] [Abstract][Full Text] [Related]
20. Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles.
Wang FB; Rong Y; Fang M; Yuan JP; Peng CW; Liu SP; Li Y
Biomaterials; 2013 May; 34(15):3816-27. PubMed ID: 23465488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
